Jump to content

Pentadecanoylcarnitine

From Wikipedia, the free encyclopedia

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)

This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (July 2024)

This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources.
Find sources: "Pentadecanoylcarnitine" – news · newspapers · books · scholar · JSTOR (July 2024)

(Learn how and when to remove this message)

Pentadecanoylcarnitine is an endocannabinoid and a metabolite of C15:0. It is an agonist at both CB1 and CB2 receptors. Also, it is an agonist at serotonin receptors (5HT1A and 5HT1B).^[1]

References

^ Venn-Watson, S.; Reiner, J.; Jensen, E. D. (2022). "Pentadecanoylcarnitine is a newly discovered endocannabinoid with pleiotropic activities relevant to supporting physical and mental health". Scientific Reports. 12 (1): 13717. Bibcode:2022NatSR..1213717V. doi:10.1038/s41598-022-18266-w. PMC 9399118. PMID 35999445.

This cannabinoid related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Pentadecanoylcarnitine&oldid=1244378279"

Hidden categories: